Literature DB >> 23529793

RANKL subcellular trafficking and regulatory mechanisms in osteocytes.

Masashi Honma1, Yuki Ikebuchi, Yoshiaki Kariya, Madoka Hayashi, Naoki Hayashi, Shigeki Aoki, Hiroshi Suzuki.   

Abstract

The receptor activator of the NF-κB ligand (RANKL) is the central player in the regulation of osteoclastogenesis, and the quantity of RANKL presented to osteoclast precursors is an important factor determining the magnitude of osteoclast formation. Because osteoblastic cells are thought to be a major source of RANKL, the regulatory mechanisms of RANKL subcellular trafficking have been studied in osteoblastic cells. However, recent reports showed that osteocytes are a major source of RANKL presentation to osteoclast precursors, prompting a need to reinvestigate RANKL subcellular trafficking in osteocytes. Investigation of molecular mechanisms in detail needs well-designed in vitro experimental systems. Thus, we developed a novel co-culture system of osteoclast precursors and osteocytes embedded in collagen gel. Experiments using this model revealed that osteocytic RANKL is provided as a membrane-bound form to osteoclast precursors through osteocyte dendritic processes and that the contribution of soluble RANKL to the osteoclastogenesis supported by osteocytes is minor. Moreover, the regulation of RANKL subcellular trafficking, such as OPG-mediated transport of newly synthesized RANKL molecules to lysosomal storage compartments, and the release of RANKL to the cell surface upon stimulation with RANK are confirmed to be functional in osteocytes. These results provide a novel understanding of the regulation of osteoclastogenesis.
© 2013 American Society for Bone and Mineral Research.

Entities:  

Keywords:  OPG; OSTEOCLASTOGENESIS; OSTEOCYTE; RANKL; SUBCELLULAR TRAFFIC

Mesh:

Substances:

Year:  2013        PMID: 23529793     DOI: 10.1002/jbmr.1941

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  40 in total

1.  Establishment of optimized in vitro assay methods for evaluating osteocyte functions.

Authors:  Masashi Honma; Yuki Ikebuchi; Yoshiaki Kariya; Hiroshi Suzuki
Journal:  J Bone Miner Metab       Date:  2014-01-01       Impact factor: 2.626

Review 2.  Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?

Authors:  R Sapir-Koren; G Livshits
Journal:  Osteoporos Int       Date:  2014-07-17       Impact factor: 4.507

3.  Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss.

Authors:  Wei Yu; Leilei Zhong; Lutian Yao; Yulong Wei; Tao Gui; Ziqing Li; Hyunsoo Kim; Nicholas Holdreith; Xi Jiang; Wei Tong; Nathaniel Dyment; X Sherry Liu; Shuying Yang; Yongwon Choi; Jaimo Ahn; Ling Qin
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

Review 4.  Mechanisms of RANKL delivery to the osteoclast precursor cell surface.

Authors:  Masashi Honma; Yuki Ikebuchi; Hiroshi Suzuki
Journal:  J Bone Miner Metab       Date:  2020-10-12       Impact factor: 2.626

Review 5.  Parathyroid hormone: anabolic and catabolic actions on the skeleton.

Authors:  Barbara C Silva; John P Bilezikian
Journal:  Curr Opin Pharmacol       Date:  2015-04-05       Impact factor: 5.547

Review 6.  The Osteocyte: New Insights.

Authors:  Alexander G Robling; Lynda F Bonewald
Journal:  Annu Rev Physiol       Date:  2020-02-10       Impact factor: 19.318

7.  Comparison of the effects of denosumab between a native vitamin D combination and an active vitamin D combination in patients with postmenopausal osteoporosis.

Authors:  Kosuke Ebina; Masafumi Kashii; Makoto Hirao; Jun Hashimoto; Takaaki Noguchi; Kota Koizumi; Kazuma Kitaguchi; Hozo Matsuoka; Toru Iwahashi; Yasunori Tsukamoto; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2016-11-09       Impact factor: 2.626

8.  Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association.

Authors:  Anthony Martin; Jian Xiong; Theodora Koromila; Jie S Ji; Stephanie Chang; Yae S Song; Jonathan L Miller; Chun-Ya Han; Paul Kostenuik; Susan A Krum; Nyam-Osor Chimge; Yankel Gabet; Baruch Frenkel
Journal:  Bone       Date:  2015-02-17       Impact factor: 4.398

Review 9.  Regulatory mechanisms of RANKL presentation to osteoclast precursors.

Authors:  Masashi Honma; Yuki Ikebuchi; Yoshiaki Kariya; Hiroshi Suzuki
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

Review 10.  Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches.

Authors:  Ernesto Canalis
Journal:  Nat Rev Endocrinol       Date:  2013-08-13       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.